Description: Researches and develops disease-modifying therapies for neurodegenerative diseases
Home Page: www.neurobopharma.com
NRBO Technical Analysis
200 Berkeley Street
Boston,
MA
02116
United States
Phone:
857-702-9600
Officers
| Name | Title |
|---|---|
| Dr. Ben Gil Price M.D. | CEO & Pres |
| Dr. Matthew Bardin BCPS, Pharm.D. | Sr. VP of Operations |
| Mr. Frank Kondrad | VP of Corp. & Bus. Devel. |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.84 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2016-08-05 |
| Fiscal Year End: | December |
| Full Time Employees: | 5 |